MedPath

The effect of sulfate magnesium on atrial fibrillation after open heart surgery

Phase 3
Recruiting
Conditions
Atrial fibrillation and fluttery.
IX 100-199 Diseases of the circulatory system
????? 148
Registration Number
IRCT20190413043252N1
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria

Only cardiopulmonary bypass graft surgery (not associated with valve operation).
First-time open heart surgery
Ejection Fraction(EF) more than 35%

Exclusion Criteria

History of Previous arterial fibrillation(AF)
History of kidney disease
History of taking magnesium and showing an allergic reaction
History of taking antiarrhythmic drugs (such as amiodarone -digoxin -warfarin)
Being pregnant
Having a pacemaker
AV BLOCK In the ECG

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect on prevention of AF rhythm in patients with coronary artery bypass graft surgery. Timepoint: 24-hour patient monitoring until the fifth day. Method of measurement: ECG monitoring.
Secondary Outcome Measures
NameTimeMethod
Reducing hospitalization time in the ICU and hospital, and thus reducing patient hospitalization costs. Timepoint: After patient's discharge from hospital. Method of measurement: Number of hospitalization days.
© Copyright 2025. All Rights Reserved by MedPath